Glaucoma secondary to intraocular tumors: mechanisms and management.
Camp DA, Yadav P, Dalvin LA, Shields CL.
Curr Opin Ophthalmol. 2019 Mar;30(2):71-81. doi: 10.1097/ICU.0000000000000550.
A review of neovascular glaucoma. Etiopathogenesis and treatment.
Dumbrăveanu L, Cușnir V, Bobescu D.
Rom J Ophthalmol. 2021 Oct-Dec;65(4):315-329. doi: 10.22336/rjo.2021.66.
Orbital indications.
Ganz JC.
Prog Brain Res. 2022;268(1):315-327. doi: 10.1016/bs.pbr.2021.10.039. Epub 2021 Dec 14.
Canine Secondary Glaucomas.
Pumphrey S.
Vet Clin North Am Small Anim Pract. 2015 Nov;45(6):1335-64, vii. doi: 10.1016/j.cvsm.2015.06.009. Epub 2015 Aug 28.
[Secondary open-angle glaucoma: uveitic secondary glaucoma, steroid-induced glaucoma, posttraumatic and postoperative glaucoma, tumor-related glaucoma and glaucoma due to elevated episcleral venous pressure].
Greslechner R, Helbig H, Spiegel D.
Ophthalmologe. 2022 May;119(5):533-546. doi: 10.1007/s00347-022-01630-6. Epub 2022 Apr 26.
Pigment-induced glaucoma secondary to bilateral diffuse uveal melanocytic proliferation.
Da Silva MV, Rose K, Krema H.
Eur J Ophthalmol. 2022 Jan;32(1):NP62-NP65. doi: 10.1177/1120672120953076. Epub 2020 Aug 25.
Ocular oncology.
Willis AM, Wilkie DA.
Clin Tech Small Anim Pract. 2001 Feb;16(1):77-85. doi: 10.1053/svms.2001.22810.
Primary Intrabulbar Neurofibroma.
Furdová A, Babál P.
Cesk Slov Oftalmol. 2020 Spring;76(2):62-67. doi: 10.31348/2020/13.
Secondary Glaucoma due to Iridescent Crystalline Particles Masquerading as Refractory Hypertensive Uveitis in an Eye With Irradiated Iris Melanoma.
Chahal R, Mohite AA, Heimann H, Bansal A.
J Glaucoma. 2018 Apr;27(4):385-388. doi: 10.1097/IJG.0000000000000891.
Melanomalytic glaucoma secondary to iris melanoma.
Ajamil Rodanés S, García-Álvarez C, Saornil Alvarez MA, López-Lara F, Frutos Baraja JM, Quiñones M.
Arch Soc Esp Oftalmol. 2017 Aug;92(8):379-381. doi: 10.1016/j.oftal.2016.08.007. Epub 2016 Oct 13.
